Peregrine Asset Advisers’s ProShares UltraShort Health Care RXD Stock Holding History

Peregrine Asset Advisers’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,318	Closed	-$205K	–	97
2017 Q1	$205K	Buy	+1,318	New	+$221K	0.11%	83

Other funds holding RXD

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Peregrine Asset Advisers's RXD Position: Q2 2017 in Review

Peregrine Asset Advisers sold out of ProShares UltraShort Health Care (RXD) in Q2 2017, closing a stake of 1,318 shares — an estimated $205K sold.

Peregrine Asset Advisers first reported a position in RXD in Q1 2017 and held it in 1 quarter. The position peaked at $205K in Q1 2017. 3 funds tracked by Wall St. Rank hold RXD as of Q2 2017.

Peregrine Asset Advisers reported no remaining ProShares UltraShort Health Care position as of Q2 2017 after selling out during the quarter.
Peregrine Asset Advisers sold 1,318 ProShares UltraShort Health Care shares in Q2 2017, an estimated $205K.
Peregrine Asset Advisers first reported a position in ProShares UltraShort Health Care in Q1 2017 and held it in 1 quarter.
Peregrine Asset Advisers's ProShares UltraShort Health Care position peaked at $205K in Q1 2017.
3 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q2 2017.

Based on Peregrine Asset Advisers's 13F filing for Q2 2017, filed 10 Aug 2017.